Categories
- PROTAC Linker
- Protein Control Ligand
- Pathway Inhibitors
- Function Modulators
- Activators
- G Protein-Coupled Receptor Ligands
- Nuclear Receptor Ligands
- GDNF Receptors
- TNF Receptors
- Transcription Factors
- Chemokines
- Cytokine Receptors
- Biomarkers and Buffer Solutions
- Molecular Probes
- Stem Cell Research
- Alzheimer's Disease
- Apoptosis
- Cancer Research
- Epigenetics
- Metabolites
- PET/SPECT Imaging Precursors
- Customized Screening Library
- Ultra Pure Pharmacological Standard
- Tissue Microarray (TMA)
- Proteins and Antibodies
- Primary Cells
- ELISA KIT
- Natural Products
- Lab Equipments
- Humanized Mice for PDX Platform
- Rare Chemicals
- Custom Synthesis
- Antibacterial
- Antifungal
- Antioxidant
- Antiviral
- Molecular Glues
- SARS-CoV
LRRC8A Antibody
NCTP06637
Description: Rabbit polyclonal to human LRRC8A
Application: ELISA, WB, IHC
Reactivity: Human
Catalog #: NCTP06637
$375.00
1000 Items
Overview
| DESCRIPTION | |
| Species Reactivity | Human. Predicted reacts with Rat, Mouse. Other species not tested. |
| Isotype | IgG |
| Immunogen | Recombinantd human LRRC8A protein 648-803aa |
| Accession # | Q8IWT6 |
| Alternative Names | Volume-regulated anion channel subunit LRRC8A, Leucine-rich repeat-containing protein 8A, Swelling protein 1, KIAA1437, LRRC8, SWELL1 |
| Purification | Purified by protein affinity column. |
| Formulation | Lyophilized with 1% BSA and 0.02% NaN3. |
| Size | 100µg/200µl |
| APPLICATION | |
| ELISA | 1:20,000-1:80,000 |
| Western Blot | 1:500-1:1,000 |
| Immunohistochemistry | 1:100-1:500 |
| - | For research use only. Optimal dilutions/concentrations should be determined by each laboratory for each application. |
| PREPARATION AND STORAGE | |
| Reconstitution | Reconstitute in 200µl of sterile H2O. |
| Storage | Shipped at ambient temperature. Store immediately at -20°C upon receipt. Avoid repeated freeze-thaw cycles. |
| REFERENCES | |
| - | Smits, G. and Kajava, A.V. LRRC8 extracellular domain is composed of 17 leucine-rich repeats. Mol. Immunol. 41 (5), 561-562 (2004) |